Navigation Links
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Date:10/21/2008

- Completion Follows FDA's Grant of Seven Years of Cinryze(TM) Marketing

Exclusivity for Prophylaxis against Hereditary Angioedema -

EXTON, Pa., Oct. 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced it has completed its acquisition of Lev Pharmaceuticals (OTC Bulletin Board: LEVP) following the approval earlier today of the transaction by Lev stockholders. Lev stockholders will receive $2.25 in cash, 0.042146 shares of ViroPharma common stock and one non- transferable contingent value right which entitles the holder to receive up to two contingent payments of $0.50 each in cash, payable upon the achievement of certain regulatory and commercial milestones, for each share of Lev common stock that they own. The total number of ViroPharma shares to be issued as part of the merger consideration is 7,286,286.

With the acquisition of Lev Pharmaceuticals, ViroPharma takes a significant step in broadening its portfolio of treatments for significant unmet medical needs, by acquiring Cinryze C1 esterase inhibitor (human), which recently received marketing approval by the U.S. Food and Drug Administration for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).

Hereditary angioedema, or C1 esterase inhibitor (C1-INH) deficiency, is a dangerous and potentially deadly inflammatory disease affecting up to 10,000 patients in the United States, caused by a genetic deficiency in an essential protein called C1 esterase inhibitor. Clinical studies have shown that prophylactic use of Cinryze, which increases the levels of C1 esterase inhibitor in the bloodstream, can significantly reduce the severity, duration and frequency of HAE attac
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
2. ViroPharma Announces Discontinuation of HCV-796 Development
3. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
4. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. ViroPharma to Present at the Natixis Bleichroeder Conference
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
9. Genta Incorporated Announces Third Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... COLORADO SPRINGS, Colo. , July 29, 2014 /PRNewswire-USNewswire/ ... remote-controlled catheter (MARC) which could allow physicians to see ... stroke may hold promise, according to study authors who ... Surgery (SNIS) 11 th Annual Meeting in ... findings stand to advance the field of neurointervention, a ...
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
(Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... June 15, 2011 The American Academy of ... 2011 AAFP Foundation Pfizer Immunization Award winners. These ... achieved increased immunization rates in their communities through ... the AAFP,s National Conference were presented to 16 ...
... June 15, 2011 To address surgeons, need for ... in open surgery, Ethicon Endo-Surgery, Inc. (EES) today announces ... advanced bipolar technology.  The new technology is designed with ... sealing vessels consistently along the length of the 40mm ...
Cached Medicine Technology:Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 2Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 3Ethicon Endo-Surgery Launches ENSEAL® G2 Super Jaw 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 Biocides are ... and control bacteria or fungi growth and to prevent ... within the material and its surface. It is used ... wood preservation, food and beverage, paints and coatings. It ... and sanitizers, as well as in industrial applications to ...
(Date:7/29/2014)... The U.S. should significantly reform the federal system ... ensure that the public,s $15 billion annual investment ... says a new report by the Institute of ... Medicare -- requires little accountability, allocates funds independent ... insufficient opportunities to train physicians in the health ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Frank Davis, ... powders can help parents add nutrition to their kids’ ... Bites – Key market drivers in kids’ foods market” ... is pleased to announce the interview Frank Davis had ... the Activz organic vegetable and fruit produce powders to ...
(Date:7/29/2014)... State College of Medicine, have jointly received nearly ... data research network., The Patient-Centered Outcomes Research Institute ... and Affordable Care Act, awarded the funds to ... Johns Hopkins University -- and each of their ... together to create a Clinical Data Research Network, ...
(Date:7/29/2014)... July 29, 2014 According to a ... the leading global authority in medical device market research, ... grow to over $8 billion by 2018. This ... in the transcatheter heart valve market, which is comprised ... the transcatheter mitral valve repair (TMVR) segments. , There ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:New network unites university health care research 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3
... officials have proposed the administration of flu vaccine to all ... attempt to prevent the incidence of seasonal flu. The dreadful ... during winter, had claimed the valuable lives of over 1000 ... Vaccination and Immunisation that addresses important medical issues and provides ...
... women who suffer from stage 1 endometrial cancer along with ... says// that this can prolong their survival. Among the gynecological ... As many as 40,000 women in the US suffer from ... data of the American Cancer Society. ,The ...
... are reforming themselves to come out of the financial ... Patricia Hewitt, British Health secretary as welcomed better financial ... more on cutting unnecessary fund wastage. ... for all the NHS hospitals will be followed and ...
... arrest in supply of blood to the brain cells, which occurs ... caused by a blocked artery and Hemorrhagic stroke is caused due ... sudden stopping of blood to the brain cells can lead to ... stroke, the survival of the stroke patients depend upon the severity ...
... the level of mental sharpness in aging individuals, according ... at Lowell//. , The researchers assessed whether ... aging mice, damage that can lead to memory loss. ... mice using a standard diet, a nutrient-deficient diet, and ...
... 250,000 early-stage glaucoma patients risk blindness due to lack of ... National Institute for the Blind (RNIB).// In an attempt to ... has been launched in the UK. ,Apart from ... from some form of visual impairment in the UK. The ...
Cached Medicine News:
... Certified by an independent laboratory ... of Federal Standard 209E. Ergonomic ... fatique and back injuries. Clean ... requirements. Static-control chairs feature dissipative ...
... SCE offers a full line of ... manufacturing and laboratory environments. Every SCE product ... / safety requirements. Now you can have ... hazardous acid / corrosive chemicals and materials ...
... Genie is an all-in-one rotator/rocker with ... five different mixing motions: rotating, ... well as a combination of all ... portion of the Vibraotme Roto-Shake Genie ...
... 55S Rocking Shaker provides the exact ... membranes. The very slow to fast ... tilt provide a gentle wave motion ... and blotted membranes to achieve faster, ...
Medicine Products: